What is the recommended icodextrin dosage (volume, concentration, and dwell time) for peritoneal dialysis in adult and pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Icodextrin Dosage for Peritoneal Dialysis

For adult and pediatric patients on peritoneal dialysis, use a single daily exchange of 7.5% icodextrin solution (typically 2.0-2.5 L in adults, 1,000-1,100 mL/m² in children) for the long dwell period of 10-16 hours. 1

Standard Dosing Parameters

Adults

  • Concentration: 7.5% icodextrin solution
  • Volume: 2.0-2.5 L per exchange 1, 2, 3
  • Dwell time: 10-16 hours for the long dwell 4, 5
  • Frequency: Once daily only 1

Pediatrics

  • Concentration: 7.5% icodextrin solution
  • Volume: 1,000-1,100 mL/m² body surface area 6, 7
  • Dwell time: 12 hours 4, 6
  • Frequency: Once daily only

Clinical Application Strategy

When to Prescribe Icodextrin

Use icodextrin for the long dwell in patients who:

  • Are high/rapid peritoneal transporters unable to achieve adequate ultrafiltration with standard glucose solutions 4
  • Have persistent fluid overload despite optimization of glucose-based exchanges 4
  • Require glucose sparing due to metabolic complications 8
  • Are anuric or have minimal residual kidney function 9

Timing of the Long Dwell

  • CAPD patients: Use for the nocturnal (overnight) dwell 4
  • APD patients: Use for the daytime dwell 4, 5

Ultrafiltration Expectations

Icodextrin provides sustained ultrafiltration of approximately 300-450 mL per exchange over the long dwell period 5, 6, 2. Importantly, ultrafiltration does not increase significantly beyond 10 hours of dwell time 5, so there is no benefit to extending dwells beyond this duration solely for ultrafiltration purposes.

The ultrafiltration achieved with icodextrin is:

  • Superior to 1.36% glucose solutions 6
  • Comparable to 3.86% hypertonic glucose solutions 6
  • Sustained throughout the entire dwell without the reabsorption seen with glucose 4

Critical Dosing Considerations

Do NOT Exceed One Daily Exchange

Current evidence supports only one icodextrin exchange per 24 hours 1, 10. Using more than one daily dwell increases the risk of:

  • Accumulation of icodextrin metabolites (particularly maltose) 3
  • False elevation of capillary glucose readings 10
  • Increased plasma osmolality 3
  • Potential for excessive ultrafiltration 10

Pediatric-Specific Considerations

Start icodextrin early (within the first year of PD initiation) in children 11. Early-start icodextrin (within 1 year) versus late-start provides:

  • Five-fold reduction in technique failure or death risk 11
  • Better blood pressure control 11
  • Preservation of residual kidney function 11
  • Improved outcomes even in children younger than 5 years 11

However, be aware that icodextrin ultrafiltration may correlate with age in very young children, with potentially less effective ultrafiltration in the youngest patients 4, though this finding requires confirmation.

Monitoring and Adjustments

What to Monitor

  • Net ultrafiltration volume with each exchange
  • Blood pressure and volume status (more important than ultrafiltration volume alone) 4
  • Residual kidney function 11
  • Plasma glucose levels (note: some glucose meters may give falsely elevated readings due to maltose cross-reactivity) 10

When Icodextrin May Be Less Effective

  • Males and high transporters tend to achieve higher ultrafiltration 5
  • Patients with very low baseline peritoneal ultrafiltration may benefit most 2
  • Age and transport characteristics affect response, but these should not preclude use 5

Common Pitfalls to Avoid

  1. Do not use icodextrin for short dwells - It requires 10+ hours to achieve optimal ultrafiltration 5
  2. Do not drain the icodextrin dwell early - Unlike glucose solutions, there is no benefit to early drainage for ultrafiltration optimization 4
  3. Do not use multiple icodextrin exchanges daily - Stick to once-daily dosing 1, 10
  4. Do not delay initiation in appropriate patients - Early use (especially in pediatrics) provides superior outcomes 11
  5. Be aware of glucose meter interference - Maltose metabolites can cause falsely elevated glucose readings with some meters 10

Route of Administration

Intraperitoneal administration only - Never use intravenously 1. The solution should be warmed to body temperature before instillation, and the bag should be inspected for leaks and clarity before use 1.

References

Research

Pharmacokinetics of icodextrin in peritoneal dialysis patients.

Kidney international. Supplement, 2002

Guideline

clinical practice guidelines for peritoneal dialysis adequacy.

American Journal of Kidney Diseases, 2006

Research

What is the optimal dwell time for maximizing ultrafiltration with icodextrin exchange in automated peritoneal dialysis patients?

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2006

Research

Nutritional effects of increasing dialysis dose by adding an icodextrin daytime dwell to Nocturnal Intermittent Peritoneal Dialysis (NIPD) in children.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.